JP2025512818A5 - - Google Patents
Info
- Publication number
- JP2025512818A5 JP2025512818A5 JP2024556786A JP2024556786A JP2025512818A5 JP 2025512818 A5 JP2025512818 A5 JP 2025512818A5 JP 2024556786 A JP2024556786 A JP 2024556786A JP 2024556786 A JP2024556786 A JP 2024556786A JP 2025512818 A5 JP2025512818 A5 JP 2025512818A5
- Authority
- JP
- Japan
- Prior art keywords
- weight
- solid dispersion
- receptor antagonist
- diseases
- disorders
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP22164462.8 | 2022-03-25 | ||
| EP22164462 | 2022-03-25 | ||
| PCT/EP2023/057791 WO2023180575A1 (en) | 2022-03-25 | 2023-03-27 | Solid composition comprising solubilised bradykinin b2-receptor antagonists |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025512818A JP2025512818A (ja) | 2025-04-22 |
| JP2025512818A5 true JP2025512818A5 (enExample) | 2026-04-06 |
Family
ID=80952146
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024556786A Pending JP2025512818A (ja) | 2022-03-25 | 2023-03-27 | 可溶化したブラジキニンｂ２受容体アンタゴニストを含む固体組成物 |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20250228781A1 (enExample) |
| EP (1) | EP4499038B1 (enExample) |
| JP (1) | JP2025512818A (enExample) |
| KR (1) | KR20240161689A (enExample) |
| CN (1) | CN119136785A (enExample) |
| AU (1) | AU2023241243A1 (enExample) |
| CA (1) | CA3250835A1 (enExample) |
| CO (1) | CO2024012879A2 (enExample) |
| ES (1) | ES3062067T3 (enExample) |
| HR (1) | HRP20260166T1 (enExample) |
| IL (1) | IL315699A (enExample) |
| MA (1) | MA69209B1 (enExample) |
| MX (1) | MX2024011703A (enExample) |
| PL (1) | PL4499038T3 (enExample) |
| WO (1) | WO2023180575A1 (enExample) |
| ZA (1) | ZA202408058B (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102824038B1 (ko) | 2025-01-20 | 2025-06-23 | 송재혁 | 차량 종합 검사 시스템 |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1168667A (zh) | 1994-10-27 | 1997-12-24 | 藤沢药品工业株式会社 | 用作缓激肽拮抗剂的吡啶并嘧啶酮，喹啉和稠合的n-杂环化合物 |
| FR2737892B1 (fr) | 1995-08-17 | 1997-10-24 | Fournier Ind & Sante | Nouveaux composes de benzenesulfonamide, procede de preparation et utilisation en therapeutique |
| GB9602029D0 (en) | 1996-02-01 | 1996-04-03 | Fujisawa Pharmaceutical Co | New heterocyclic compounds |
| DE19609827A1 (de) | 1996-03-13 | 1997-09-18 | Hoechst Ag | Aminoalkyl- und Acylaminoalkylether, Verfahren zu deren Herstellung und ihre Verwendung als Bradykinin-Rezeptorantagonisten |
| DE19610784A1 (de) | 1996-03-19 | 1997-09-25 | Hoechst Ag | Fluoralkyl- und Fluoralkoxysubstituierte heterocyclische Bradykinin-Antagonisten, Verfahren zu ihrer Herstellung und ihre Verwendung |
| AUPN952696A0 (en) | 1996-04-29 | 1996-05-23 | Fujisawa Pharmaceutical Co., Ltd. | New heterocyclic compounds |
| DE19712960A1 (de) | 1997-03-27 | 1998-10-01 | Hoechst Ag | Benzyloxy-substituierte, anellierte N-Heterocyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Bradykininrezeptorantagonisten |
| EP1085895A1 (en) | 1998-06-08 | 2001-03-28 | Advanced Medicine, Inc. | Bradykinin antagonists |
| EP1123288A1 (en) | 1998-10-21 | 2001-08-16 | Fujisawa Pharmaceutical Co., Ltd. | Vitreous form of known bradykinin antagonist |
| FR2790260B1 (fr) | 1999-02-26 | 2001-05-04 | Fournier Ind & Sante | Nouveaux composes de n-(benzenesulfonamide), procede de preparation et utilisation en therapeutique |
| CA2364178C (en) | 2000-12-05 | 2006-01-10 | Yasuhiro Katsu | N-benzenesulfonyl l-proline compounds as bradykinin antagonists |
| JP2005525398A (ja) | 2002-04-10 | 2005-08-25 | オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド | ブラジキニン受容体モジュレーターとして有用な新規なヘテロアリールアルキルアミド誘導体 |
| ITMI20021247A1 (it) | 2002-06-07 | 2003-12-09 | Menarini Ricerche Spa | Antagonisti basici non peptidici della bradichinina e loro impiego informulazioni farmaceutiche |
| ITMI20041963A1 (it) | 2004-10-15 | 2005-01-15 | Luso Farmaco Inst | "antagonisti non-peptidici della bradichinina e loro composizioni farmaceutiche" |
| TWI407960B (zh) | 2007-03-23 | 2013-09-11 | Jerini Ag | 小分子緩激肽ｂ２受體調節劑 |
| AR073304A1 (es) | 2008-09-22 | 2010-10-28 | Jerini Ag | Moduladores del receptor de bradiquinina b2 de molecula pequena |
| KR20150127718A (ko) | 2013-03-14 | 2015-11-17 | 샤이어 휴먼 지네틱 테라피즈 인크. | Ｂ2-브라디키닌 수용체 매개 혈관부종의 치료 방법 |
| SMT202200154T1 (it) | 2017-11-24 | 2022-05-12 | Pharvaris Netherlands B V | Nuovi antagonisti del recettore della bradichinina b2 |
| AR118983A1 (es) * | 2019-05-23 | 2021-11-17 | Pharvaris Gmbh | Antagonistas cíclicos del receptor b2 de bradiquinina |
| CA3198246A1 (en) * | 2020-11-12 | 2022-05-19 | Pharvaris Gmbh | Prophylaxis and treatment of angioedema |
-
2023
- 2023-03-27 HR HRP20260166TT patent/HRP20260166T1/hr unknown
- 2023-03-27 AU AU2023241243A patent/AU2023241243A1/en active Pending
- 2023-03-27 CA CA3250835A patent/CA3250835A1/en active Pending
- 2023-03-27 PL PL23715487.7T patent/PL4499038T3/pl unknown
- 2023-03-27 US US18/850,679 patent/US20250228781A1/en active Pending
- 2023-03-27 EP EP23715487.7A patent/EP4499038B1/en active Active
- 2023-03-27 WO PCT/EP2023/057791 patent/WO2023180575A1/en not_active Ceased
- 2023-03-27 ES ES23715487T patent/ES3062067T3/es active Active
- 2023-03-27 IL IL315699A patent/IL315699A/en unknown
- 2023-03-27 KR KR1020247035351A patent/KR20240161689A/ko active Pending
- 2023-03-27 JP JP2024556786A patent/JP2025512818A/ja active Pending
- 2023-03-27 MA MA69209A patent/MA69209B1/fr unknown
- 2023-03-27 CN CN202380037794.6A patent/CN119136785A/zh active Pending
-
2024
- 2024-09-24 CO CONC2024/0012879A patent/CO2024012879A2/es unknown
- 2024-09-24 MX MX2024011703A patent/MX2024011703A/es unknown
- 2024-10-24 ZA ZA2024/08058A patent/ZA202408058B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6273302B2 (ja) | １日１回の投与で薬理学的臨床効果を提供するモサプリド徐放性製剤 | |
| JP5827236B2 (ja) | シグマレセプターリガンドを含む医薬組成物 | |
| ES2935800T3 (es) | Forma de dosificación oral de ketamina | |
| CN111093653B (zh) | 氘代多潘立酮组合物、方法和制备物 | |
| KR20090042967A (ko) | 플리반세린 제형 및 이의 제조방법 | |
| CN107468667A (zh) | 包含蒙特鲁卡斯特及左旋西替利的胶囊调配物 | |
| CN102946871A (zh) | 曲马多和昔布类（Coxibs）的共晶体的药物组合物 | |
| WO2011110939A2 (en) | Pharmaceutical compositions of substituted benzhydrylpiperazines | |
| CN110114063A (zh) | 鲁拉西酮固体分散体及其制备方法 | |
| WO2013020416A1 (zh) | 伊伐布雷定或其可药用盐的缓释制剂 | |
| CN101631533A (zh) | 含有西洛他唑的控释制剂及其制备方法 | |
| JP2013504615A (ja) | 溶出率向上と副作用発現が最小化されたシルロスタゾール徐放錠 | |
| CN108012526A (zh) | 具有改进的生物利用度的含普仑司特固体制剂的组合物及其制备方法 | |
| CN102470121A (zh) | 包含决奈达隆的药物组合物 | |
| WO2025214247A1 (zh) | 恩扎卢胺药物组合物及其制备方法和用途 | |
| CN102198107B (zh) | 拉西地平分散片及其制备方法 | |
| CN104487057A (zh) | 波生坦控释口服制剂 | |
| KR101076648B1 (ko) | 제어 방출성 아세클로페낙을 함유하는 경구 제제의 조성물 및 그의 제조방법 | |
| JP7837967B2 (ja) | 抗眩暈組成物及びその医薬組成物 | |
| WO2017182641A1 (en) | Bilayer tablet formulations of montelukast and rupatadine | |
| KR20170001545A (ko) | 모사프리드 서방성 제제 및 모사프리드와 라베프라졸의 복합제제 | |
| WO2021057881A1 (zh) | 一种奥司他韦制剂 | |
| CN104856971A (zh) | 一种脉冲双释放制剂及其制备方法与应用 | |
| JP6259043B2 (ja) | 溶出率向上と副作用発現が最小化されたシルロスタゾール徐放錠 | |
| JP2025510860A5 (enExample) |